 |
| PZOO Pops BICX Rebounds on Good News Is ABHI Next? |
|
 Hot Stock to Watch
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.1298
Change (%): + 0.0099 (8.26)
Volume: 127,586 |
 |
In a New Audio Interview at SmallCapVoice.com, BioCorRx, Inc. Chief Financial Officer Lourdes Felix and Chief Operating Officer Brady Granier Discuss Recently Filed Q1 Financials and Other Current Events
AUSTIN, Texas, May 19, 2014 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTCQB:BICX), a leader in addiction treatment programs, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-16-14-smallcapvoice-interview-with-biocorrx-inc-bicx
“By focusing on branding and expansion to reach mass market adoption, BioCorRx Inc. will continue to position its Start Fresh Program as a leader in treating alcohol and opioid addiction,” stated Lourdes Felix.
Continue Reading
|
Company: AmbiCom Holdings, Inc. (OTCQB: ABHI)
|
End of Day:
Price: 0.35
Change (%): + 0.00 (0.00)
Volume: 682 |
 |
In a New Audio Interview at SmallCapVoice.com, AmbiCom Holdings, Inc. President Kevin Cornell and Chief Executive Officer John Hwang, Discuss the Recently Announced Asset Purchase Agreement and Exciting Future Plan
AUSTIN, Texas, May 20, 2014 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with AmbiCom Holdings, Inc. (OTCQB:ABHI), a leading designer and developer of innovative wireless hardware and software products targeting the healthcare market with more than one million devices sold worldwide, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-16-14-smallcapvoice-interview-with-ambicom-holdings-inc-abhi.
Kevin Cornell and John Hwang called into SmallCapVoice.com to provide the listening audience with a comprehensive overview of the history for both AmbiCom Holdings, Inc. and Veloxum Corporation, the highlights on the amazing year for the Company that was 2013, as well as his own candid insights into the goals for the Company in 2014.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Pazoo, Inc. (OTCQB: PZOO)
|
End of Day:
Price: 0.051
Change (%): + 0.001 (2.00)
Volume: 92,635 |
 |
Traffic Surges to All Time Record of More Than 200,000 Visitors in One Day on WWW.PAZOO.COM
WHIPPANY, NJ--(Marketwired - May 20, 2014) - Pazoo, Inc. (OTCQB: PZOO) (German WKN#: A1J3DK) is pleased to report that for the first time traffic surged to more than 200,000 visitors in one day on www.pazoo.com. Traffic never stays exactly the same from day to day as it fluctuates up and down depending on social media initiatives and marketing efforts. However, it is a major milestone for Pazoo to have reached 200,000 visitors one day in the past week.
There has been a meteoric increase in traffic over the past 6 weeks on www.pazoo.com. Over the coming days and weeks Pazoo management will now be focused on optimizing the earnings per CPM to increase the gross profit margins from Pazoo's advertising providers. Additionally there will be a push to increase the amount of the high paying pre-roll, also known as video ads, on the website. Once this optimization of ad revenue reaches targeted levels, another large scale marketing push will be instituted.
Continue Reading |
Other Small Cap News
|
Company: Nuvilex, Inc. (OTCQB: NVLX)
|
Nuvilex Positioned for Lucrative Deal With Cell-in-a-Box Technology's Diverse Treatments Amid Biotech Frenzy
NEW YORK, NY--(Marketwired - May 20, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is up to much more than most are currently aware of, and it only takes a bit of digging to realize it. The company is clearly out to extend the survival time of patients with advanced inoperable pancreatic cancer in its upcoming Phase 2b clinical trial, but reading the recently changed language in Nuvilex's "About Nuvilex" section of its press releases, and it's also clear they're not stopping there. It is the company's diversity with not only pancreatic cancer, but with other cancers and diabetes, that has it positioned for what could potentially be a lucrative deal with a much larger pharmaceutical firm.
The new language in Nuvilex's press releases reads: Nuvilex is also working towards clinical trials associated with the symptoms of advanced pancreatic cancer and other abdominal cancers.
Continue Reading
|
Company: SANUWAVE Health, Inc. (OTCBB: SNWV)
|
SANUWAVE Receives U.S. Patent for Stem Cell Treatments Using Shock Wave Technology
ALPHARETTA, Ga., May 20, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today received a patent issued by the U.S. Patent and Trademark Office entitled "Use of Pressure Waves for Stimulation, Proliferation, Differentiation and Post-Implantation Viability of Stem Cells." The claims of the patent (patent number 8,728,809) relate to the use of shock waves for stimulation of proliferation inside the body of donor stem cells. The proliferated donor stem cells are then harvested for further laboratory proliferation to create either autologous or allogeneic transplant cells. In another step, shock waves are used to pre-treat the targeted location for tissue regeneration, to stimulate blood vessel formation and thus increase survival rate for transplanted stem cells. Furthermore, the methods of this patent include the application of shock waves after stem cell transplantation in the recipient area to accelerate and enhance tissue reconstruction. The patent life extends to August 2031.
Continue Reading |
Market News
|
By Sui-Lee Wee: Reuters
|
China confronts U.S. envoy over cyber-spying accusations
BEIJING (Reuters) - China summoned the U.S. ambassador after the United States accused five Chinese military officers of hacking into American companies to steal trade secrets, warning Washington it could take further action, the foreign ministry said on Tuesday.
The U.S. Ambassador to China, Max Baucus, met with Zheng Zeguang, assistant foreign minister, on Monday shortly after the United States charged the five Chinese, accusing them of hacking into American nuclear, metal and solar companies to steal trade secrets.
Zheng "protested" the actions by the United States, saying the indictment had seriously harmed relations between both countries, the foreign ministry said in a statement on its website.
Continue Reading
|
By Maxwell Meyers: Talking Numbers
|
Talking Numbers - CNBC | Yahoo Finance
Cal Ripken’s 2,632 consecutive starts. DiMaggio’s 56 straight games with a hit. Those streaks pale in comparison to what’s happening in the market right now.
That’s because the S&P has gone 468 days since experiencing a correction of 10 percent or more. That’s the fourth longest streak on record, according to Newedge.
Still not impressed? How about this: The S&P hasn’t closed below its 200-day moving average in over 18 months. Waiting for the correction has become an absurdist activity, the financial equivalent of “Waiting for Godot.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
